| Sun Pharma Advanced Research Company Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532872 |
NSE Symbol : SPARC |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE232I01014 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : -10.75 |
Market Cap(₹Cr) : 4,960.31 |
Face Value(₹) : 1.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 71.77 | 75.55 | 238.78 | 137.25 | 252.96 |
| Other Income | 1.79 | 29.47 | 10.88 | 6.84 | 5.41 |
| Stock Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income | 73.56 | 105.02 | 249.66 | 144.09 | 258.37 |
| EXPENDITURE : | |||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 18.27 | 18.18 |
| Power and Fuel Cost | 6.33 | 6.14 | 5.75 | 4.62 | 4.60 |
| Other Manufacturing Expenses | 48.01 | 55.37 | 45.51 | 17.06 | 17.93 |
| Selling and Administration Expenses | 230.99 | 292.27 | 289.71 | 183.33 | 252.17 |
| Miscellaneous Expenses | 4.75 | 7.03 | 4.87 | 2.41 | 3.48 |
| Employee Benefit Expenses | 108.96 | 118.53 | 107.00 | 98.31 | 91.59 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | -325.48 | -374.32 | -203.18 | -179.90 | -129.57 |
| Interest | 8.91 | 1.66 | 7.63 | 13.33 | 10.65 |
| Gross Profit | -334.39 | -375.98 | -210.81 | -193.23 | -140.22 |
| Depreciation | 10.83 | 12.13 | 11.77 | 10.16 | 10.92 |
| Profit Before Tax | -345.22 | -388.11 | -222.58 | -203.39 | -151.14 |
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Net Profit | -345.22 | -388.11 | -222.58 | -203.40 | -151.14 |
| Extraordinary Items | 0.03 | 0.58 | -0.11 | 4.89 | 0.26 |
| Adjusted Net Profit | -345.25 | -388.69 | -222.47 | -208.29 | -151.40 |
| Adjustment below Net Profit | -0.26 | 0.19 | 1.35 | 1.70 | 1.53 |
| Profit/Loss Balance carried down | -1,979.73 | -1,591.81 | -1,370.58 | -1,168.88 | -1,019.27 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -2,325.21 | -1,979.73 | -1,591.81 | -1,370.58 | -1,168.88 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | -10.64 | -11.96 | -6.86 | -7.48 | -5.77 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | -6.80 | 3.85 | 15.80 | -7.47 | -6.42 |
| Book Value(Adj)-Unit Curr | -6.80 | 3.85 | 15.80 | -7.47 | -6.42 |